Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biopharma Investing In Better Success Rates Via AI, Data And New Modalities

Executive Summary

Biopharma executives and investors gathered in San Diego on Feb. 28 and March 1 to talk about finding and funding innovation with a focus on novel technology and artificial intelligence that can improve drug discovery and development success rates.
Advertisement

Related Content

Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline
Preparing Emerging Biotechs For The Best Deals – Insider Insights
FDA Approves First Digital Pill: Otsuka/Proteus' Abilify MyCite
Amazon-Express Scripts Partnership? PBM Sees Opportunity In Uninsured Market
Bayer/Versant Launch New Stem Cell Company With Massive Cash Injection
GSK And Google To Invest £540m In UK-Headquartered Bioelectronics JV
Bayer And CRISPR Form Cutting Edge Gene Editing JV

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100492

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel